Metraipolis › archive › dc_afdf2195db63

Mast cell driven immunometabolism as a therapeutic entry point in ESCC — Europe PMC PMID:42199342

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42199342
DOI
10.3389/fcell.2026.1830394
License (as archived)
solo-consultazione
Archived
2026-11-02T12:37:12.832Z
SHA-256 of the archived text
7634014d7af64dd1048e040a91c49186c294f2fed15cc928fc1903ce7a574e0e
Stable URL of this page
https://metraipolis.com/documento/dc_afdf2195db63

How to cite

Mast cell driven immunometabolism as a therapeutic entry point in ESCC — Europe PMC PMID:42199342 — Europe PMC (en), https://europepmc.org/article/MED/42199342 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_afdf2195db63 (Metraipolis archive dc_afdf2195db63, sha256 7634014d7af64dd1048e040a91c49186c294f2fed15cc928fc1903ce7a574e0e)
BibTeX
@misc{dcafdf2195db63,
  title = {Mast cell driven immunometabolism as a therapeutic entry point in ESCC — Europe PMC PMID:42199342},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42199342},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_afdf2195db63; sha256 7634014d7af64dd1048e040a91c49186c294f2fed15cc928fc1903ce7a574e0e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42199342. Agents can read the archived copy with the MCP tool read_document.